IBDEI1A7 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21794,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,21794,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,21794,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,21795,0)
 ;;=L27.1^^87^970^266
 ;;^UTILITY(U,$J,358.3,21795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21795,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,21795,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,21795,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,21796,0)
 ;;=L29.0^^87^970^250
 ;;^UTILITY(U,$J,358.3,21796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21796,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,21796,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,21796,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,21797,0)
 ;;=L29.9^^87^970^251
 ;;^UTILITY(U,$J,358.3,21797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21797,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,21797,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,21797,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,21798,0)
 ;;=L30.0^^87^970^232
 ;;^UTILITY(U,$J,358.3,21798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21798,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,21798,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,21798,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,21799,0)
 ;;=L30.1^^87^970^140
 ;;^UTILITY(U,$J,358.3,21799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21799,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,21799,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,21799,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,21800,0)
 ;;=L30.2^^87^970^132
 ;;^UTILITY(U,$J,358.3,21800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21800,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,21800,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,21800,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,21801,0)
 ;;=L30.4^^87^970^144
 ;;^UTILITY(U,$J,358.3,21801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21801,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,21801,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,21801,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,21802,0)
 ;;=L30.8^^87^970^135
 ;;^UTILITY(U,$J,358.3,21802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21802,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,21802,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,21802,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,21803,0)
 ;;=L30.9^^87^970^136
 ;;^UTILITY(U,$J,358.3,21803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21803,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21803,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,21803,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,21804,0)
 ;;=L40.0^^87^970^253
 ;;^UTILITY(U,$J,358.3,21804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21804,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,21804,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,21804,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,21805,0)
 ;;=L40.1^^87^970^256
 ;;^UTILITY(U,$J,358.3,21805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21805,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,21805,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,21805,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,21806,0)
 ;;=L40.2^^87^970^11
 ;;^UTILITY(U,$J,358.3,21806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21806,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,21806,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,21806,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,21807,0)
 ;;=L40.3^^87^970^255
 ;;^UTILITY(U,$J,358.3,21807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21807,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,21807,1,4,0)
 ;;=4^L40.3
